High dose methadone and ventricular arrhythmias: A report of three cases

Pain

Volumn 103, Issue 3, 2003, Pages 321-324

  Walker, Paul W ^a   Klein, Douglas ^b   Kasza, Leslie ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

CYP3A4; Methadone; Torsades de pointes; Ventricular arrhythmia

Indexed keywords

ACETYLSALICYLIC ACID; CYTOCHROME P450 3A4; DIGOXIN; DILTIAZEM; ENALAPRIL; ESTROGEN; FENTANYL; FLAVOXATE; FLUOXETINE; GABAPENTIN; HETASTARCH; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INFUSION FLUID; ISOENZYME; LACTULOSE; LIDOCAINE; MAGNESIUM DERIVATIVE; METHADONE; MIDAZOLAM; MORPHINE; POTASSIUM; PROGESTERONE; RANITIDINE; SERTRALINE; TRIMIPRAMINE; ZOPICLONE;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACKACHE; CANCER PAIN; CASE REPORT; CHRONIC PAIN; DEFIBRILLATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; DRUG SAFETY; ELECTROCARDIOGRAM; FATIGUE; FEMALE; HEART ATRIUM PACEMAKER; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; LABORATORY TEST; LUNG EDEMA; NEUROPATHIC PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QT INTERVAL; SINUS RHYTHM; TORSADE DES POINTES; VERTIGO;

EID: 0037683288     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00461-X     Document Type: Article

References (16)

1. Alderman C.P., Frith P.A. Fluvoxamine-methadone interaction. Aust N Z J Psychiatry. 33:1999;99-101.
2. Bareis D.L., Slotkin T.A. Responses of heart ornithine decarboxylase and adrenal catecholamines to methadone and sympathetic stimulants in developing and adult rats. J Pharmacol Exp Ther. 205:1978;164-174.
3. Bertschy G., Eap C.B., Powell K., Baumann P. Fluoxetine addition to methadone in addicts: pharmacokinetic aspects. Ther Drug Monit. 18:(5):1996;570-572.
4. Canadian Adverse Drug Reaction Newsletter. Drugs causing prolongation of QT interval and torsades de pointes. Can Med Assoc J. 158:(1):1998;103.
5. Cobb M.N., Desai J., Brown L.S., Zannikos P.N., Rainey P.M. The effect of fluconazole on the clinical pharmacokinetics of methadone. Clin Pharmacol Ther. 63:(6):1998;655-662.
6. Deamer R.L., Wilson D.R., Clark D.S., Prichard J.G. Torsades de pointes associated with high dose levomethadyl acetate. J Addict Dis. 20:2001;7-14.
7. Helpern M. Fatalities from narcotic addiction in New York city. Hum Pathol. 3:(1):1972;13-21.
8. Kreek M.J., Garfield J.W., Gutjahr C.L., Giusti L.M. Rifampin-induced methadone withdrawal. N Engl J Med. 294:(20):1976;1104-1106.
9. DHHS publication number (ADM)81-1029 Langou R., Cohen L.S. Survey of the cardiovascular effects of chronic methadone ingestion. Kleber H.D., Mezritz M. Medical evaluation of long-term methadone-maintained clinics. 1980;3-10 NIDA, Rockville, MD.
10. Lipski J., Stimmel B., Donoso E. The effect of heroin and multiple drug abuse on the electrocardiogram. Am Heart J. 86:(5):1973;663-668.
11. Mantelli L., Corti V., Bini R., Cerbai E., Ledda F. Effects of DL-methadone on the response to physiological transmitters and on several functional parameters of the isolated guine-pig heart. Arch Int Pharmacodyn. 282:1986;293-313.
12. Michalets E.L. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy. 18:(1):1998;84-112.
13. Ripamonti C., Groff L., Brunelli C., Polastri D., Stavrakis A., De Conno F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol. 16:(10):1998;3216-3221.
14. Tong T.G., Pond S.M., Kreek M.J., Jaffery N.F., Benowitz N.L. Phenytoin-induced methadone withdrawal. Ann Intern Med. 94:1981;349-351.
15. Viskin S. Long QT syndromes and torsades de pointes. Lancet. 354:1999;1625-1633.
16. Watanabe S., Belzile M., Kuehn N., Hanson J., Bruera E. Capsules and supporitories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations. Cancer Treat Rev. 22:(suppl. A):1996;131-136.